RNU6-971P

Across TCGA pan-cancer cohorts, RNU6-971P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-971P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNU6-971P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-971P expression acts as an unfavorable survival marker.

THCA, UCEC, and STAD are the cancer types where RNU6-971P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.518	0.951	<.001	69	view →
UCEC	OS	Tertile	All	0.737	0.929	.005	30	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	27	view →
CESC	DFS	Tertile	III,IV	0.185	0.634	.010	18	view →
LUSC	DFS	Tertile	III,IV	0.117	0.784	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-971P–THCA (OS)

Open the THCA breakdown →